Breast Cancer Clinical Trial

Effect of Dietary Soy on Estrogens in Breast Fluid, Blood, and Urine Samples From Healthy Women

Summary

RATIONALE: Chemoprevention is the use of certain drugs to keep cancer from forming. Eating a diet high in isoflavones, compounds found in soy foods, may keep cancer from forming.

PURPOSE: This randomized phase III trial is studying the effects of dietary soy on estrogens in breast fluid, blood, and urine samples from healthy women.

View Full Description

Full Description

OBJECTIVES:

Examine the effects of two daily servings of soy on estrogen levels in nipple aspirate fluid (NAF) and serum.
Investigate cytologic patterns of epithelial breast cells obtained from NAF as a measure of proliferation in relation to soy intake.
Explore the effect of two daily servings of soy on cytochrome alterations of estrogen metabolism as expressed in the formation of urinary 2-, 16α-, and 4-hydroxy estrogen metabolites.
Compare estrogen levels in NAF and serum measured at the same time during the luteal phase.

OUTLINE: This is a multicenter study. Participants are randomized to 1 of 2 intervention arms.

Arm I: Participants partake in a high soy diet consisting of 2 daily soy servings (approximately 50mg isoflavones). The choice of soy foods will include ½ cup of tofu, ¾ cup of soy milk, or ¼ cup of soy nuts. Replacement of currently consumed foods with soy foods will be encouraged.
Arm II: Participants will be asked to keep their soy intake below 3 servings per week. The participants will also receive general nutrition counseling.

In both arms, intervention continues for 6 months. After 6 months, participants undergo a 1-month washout period and then cross-over to the other intervention arm.

Nipple aspirate fluid, urine, and blood samples are collected periodically to measure laboratory endpoints.

View Eligibility Criteria

Eligibility Criteria

DISEASE CHARACTERISTICS:

Healthy participant

No diagnosis of cancer

PATIENT CHARACTERISTICS:

Premenopausal
Regular menstrual cycles

PRIOR CONCURRENT THERAPY:

Not taking birth control pills or other hormones

Study is for people with:

Breast Cancer

Phase:

Phase 3

Estimated Enrollment:

100

Study ID:

NCT00513916

Recruitment Status:

Completed

Sponsor:

University of Hawaii Cancer Research Center

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

Cancer Research Center of Hawaii
Honolulu Hawaii, 96813, United States

How clear is this clinincal trial information?

Study is for people with:

Breast Cancer

Phase:

Phase 3

Estimated Enrollment:

100

Study ID:

NCT00513916

Recruitment Status:

Completed

Sponsor:


University of Hawaii Cancer Research Center

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider